Market revenue in 2023 | USD 100.4 million |
Market revenue in 2030 | USD 142.0 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Optical |
Fastest growing segment | Multi Modal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CT, MRI, PET/SPECT, Multi Modal, Optical, Ultrasound, Photoacoustic, Reagents, Services |
Key market players worldwide | Bruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preclinical imaging market will help companies and investors design strategic landscapes.
Optical was the largest segment with a revenue share of 14.04% in 2023. Horizon Databook has segmented the Italy preclinical imaging market based on ct, mri, pet/spect, multi modal, optical, ultrasound, photoacoustic, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The government of Italy is the primary purchaser of medical equipment in the country. Public hospitals account for around 75% of sales of medical devices, while the remaining 25% of sales are made to the private sector. Italy's healthcare system is a regionally based national health service that provides universal coverage, largely free of charge at the point of delivery.
Italy's preclinical imaging market is expanding, and there are numerous opportunities for U.S. companies. Surgical procedure equipment, including preclinical imaging devices, are among the best avenues for growth in the country.
The development of novel in vivo imaging agents, such as contrast agents and radiotracers, is expanding the capabilities of preclinical imaging in Italy. These agents are used to enhance the visibility of specific biological targets or processes, enabling researchers to obtain more precise and detailed images. Therefore, such advancements are expected to fuel market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy preclinical imaging market , including forecasts for subscribers. This country databook contains high-level insights into Italy preclinical imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account